Crespo-Facorro Benedicto, Pelayo-Terán José María, Pérez-Iglesias Rocío, Ramírez-Bonilla Mariluz, Martínez-García Obdulia, Pardo-García Gema, Vázquez-Barquero José Luis
Hospital Universitario Marqués de Valdecilla, Department of Psychiatry, School of Medicine, Planta 2a, Edificio 2 de Noviembre, Avda. Valdecilla s/n, 39008, Santander, Spain.
J Psychiatr Res. 2007 Oct;41(8):659-66. doi: 10.1016/j.jpsychires.2006.05.002. Epub 2006 Jun 23.
Approximately 60% of patients with a first episode of psychosis will significantly reduce the severity of their positive symptomatology with antipsychotic drugs. The aim of this study was to investigate predictors of response to antipsychotic treatment during the first episode of non-affective psychosis. 172 patients (107 male) with a diagnosis of schizophreniform, schizophrenia, schizoaffective, brief reactive psychosis, schizotypal personality disorder or psychosis non-otherwise specified entered the study. Sociodemographic, premorbid and clinical data at baseline were evaluated. Unpaired t-test for continuous and chi2 for categorical data, respectively, were used to compare responders and non-responders selected variables. Multivariate logistic regression was used to establish a prediction model. 57.6% of study subjects (99 of 172) responded to antipsychotic treatment. The following variables were significantly associated with less likelihood of response: 1.--lower severity of general psychopathology, positive symptoms and disorganized symptoms at baseline; 2.--earlier age of onset; 3.--diagnosis of schizophrenia; 4.--longer DUP; 5.--poorer premorbid adjustment during adolescence, and 6.--hospitalization. Multivariate logistic regression demonstrated that differences between responders and non-responders were largely accounted for by BPRS total score, age of onset, premorbid adjustment at early adolescence, and diagnosis. Patients with an early age of onset of schizophrenia, a poor premorbid adolescent functioning, and with a lower severity of psychopathology at intake seem to have a decrease likelihood of responding to antipsychotic treatment. Helping clinicians to identify non-responders is meant as a first step to optimise therapeutic effort to benefit individuals in this vulnerable group.
大约60%的首发精神病患者使用抗精神病药物后其阳性症状的严重程度会显著降低。本研究的目的是调查非情感性精神病首发期间抗精神病治疗反应的预测因素。172例诊断为精神分裂症样、精神分裂症、分裂情感性、短暂反应性精神病、分裂型人格障碍或未另行特指的精神病患者进入研究。评估了基线时的社会人口统计学、病前和临床数据。分别使用连续变量的非配对t检验和分类数据的卡方检验来比较反应者和无反应者的选定变量。采用多因素逻辑回归建立预测模型。57.6%的研究对象(172例中的99例)对抗精神病治疗有反应。以下变量与反应可能性较低显著相关:1. 基线时一般精神病理学、阳性症状和紊乱症状的严重程度较低;2. 发病年龄较早;3. 精神分裂症诊断;4. 病程较长;5. 青春期病前适应较差;6. 住院治疗。多因素逻辑回归表明,反应者和无反应者之间的差异在很大程度上由简明精神病评定量表总分、发病年龄、青春期早期病前适应和诊断所解释。精神分裂症发病年龄早、青春期病前功能差且入院时精神病理学严重程度较低的患者对抗精神病治疗有反应的可能性似乎降低。帮助临床医生识别无反应者是优化治疗努力以使这一弱势群体中的个体受益的第一步。